Other Current Liabilities |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2026 | |||||||||||||||||||||||||||||||||||||||||||||
| Other Current Liabilities | |||||||||||||||||||||||||||||||||||||||||||||
| Other Current Liabilities |
Other current liabilities for the periods presented are comprised of the following (in thousands):
Current liabilities include $105.0 million related to advance payments received from Hologen in connection with the strategic collaboration. These amounts represent non-refundable upfront payments received prior to the Hologen Initial Closing Date as described in Note 1. |
||||||||||||||||||||||||||||||||||||||||||||